What Are Gram-Positive Infections?
Gram-positive infections are bacterial infections caused by organisms that retain crystal violet dye in the Gram staining process due to their thick peptidoglycan cell wall, with the most clinically significant pathogens being Staphylococcus aureus (including MRSA), streptococci (including Streptococcus pneumoniae and S. pyogenes), enterococci, and Clostridium species.
Major Gram-Positive Pathogens
Staphylococci
- Staphylococcus aureus: The most frequently isolated Gram-positive pathogen, causing skin and soft-tissue infections, bacteremia, endocarditis, and osteomyelitis 1, 2
- Methicillin-resistant S. aureus (MRSA): Both hospital-acquired (HA-MRSA) and community-acquired (CA-MRSA) strains represent major therapeutic challenges 3, 4
- Coagulase-negative staphylococci (particularly S. epidermidis): Important in device-related infections 5
Streptococci
- Streptococcus pyogenes (Group A Streptococcus): Causes cellulitis, necrotizing fasciitis, and toxic shock syndrome 5
- Viridans streptococci: Increasingly important in neutropenic patients and endocarditis 1
- Streptococcus pneumoniae: Leading cause of community-acquired pneumonia, with penicillin-resistant strains emerging globally 6
Enterococci
- Enterococcus faecalis and E. faecium: Common in intra-abdominal infections, urinary tract infections, and bloodstream infections 7
- Vancomycin-resistant enterococci (VRE) pose significant treatment challenges 8, 4
Anaerobic Gram-Positive Bacteria
- Clostridium perfringens: Causes gas gangrene (myonecrosis) 1
- Clostridium difficile: Major cause of antibiotic-associated colitis 6
- Peptostreptococcus species: Found in polymicrobial intra-abdominal infections 7
Clinical Infection Types
Skin and Soft-Tissue Infections
Gram-positive cocci, particularly S. aureus and streptococci, are the predominant pathogens in:
- Cellulitis and erysipelas
- Surgical site infections (especially in cardiothoracic and orthopedic surgery) 9
- Diabetic foot infections (where therapy aimed solely at aerobic Gram-positive cocci may suffice for mild-to-moderate infections) 10
- Necrotizing fasciitis and myonecrosis 1
Bloodstream Infections
S. aureus, streptococci, and enterococci are the most frequent causative organisms of bacteremia and infective endocarditis 11. Complicated bacteremia with metastatic foci requires prolonged treatment and source control.
Intra-Abdominal Infections
While Gram-negative bacteria predominate, Gram-positive organisms play important roles:
- Streptococci (particularly S. milleri group) are commonly present in colon-derived infections 7
- Enterococci are frequently isolated but empiric coverage is not routinely necessary in community-acquired infections 7
Infections in Immunocompromised Hosts
In neutropenic patients, Gram-positive organisms cause 30-40% of subsequent infections, with antibiotic-resistant strains (MRSA, VRE) being particularly problematic 1. More virulent Gram-positive organisms like S. aureus and viridans streptococci require specific antimicrobial coverage considerations 1.
Resistance Patterns
The landscape of Gram-positive infections is increasingly complicated by antimicrobial resistance 4, 6:
- MRSA: Widespread in both hospital and community settings, with some strains showing intermediate or full resistance to vancomycin (VISA/VRSA) 3, 4
- Penicillin-resistant S. pneumoniae: Major community pathogen in many regions 6
- VRE: Established hospital pathogen with limited treatment options 8, 4
- Clindamycin resistance: Now very common in CA-MRSA 3
Treatment Implications
For mild-to-moderate community-acquired infections, therapy targeting aerobic Gram-positive cocci alone is often sufficient, particularly in patients without recent antibiotic exposure 10.
For severe infections or those with resistant organisms, broader coverage is required with agents such as:
- Vancomycin (though empiric use should be restricted and discontinued if cultures remain negative at 72-96 hours) 1
- Linezolid (particularly effective for MRSA skin infections and VRE) 3
- Daptomycin (for complicated bacteremia and endocarditis) 3, 11
- Newer agents including ceftaroline, tedizolid, and dalbavancin 3, 12
The choice of empirical therapy must consider local antibiotic susceptibility patterns, particularly the prevalence of MRSA and other resistant organisms 10, 3.